New pill tested for common skin condition
NCT ID NCT05725057
Summary
This study tested a new oral medication called AX-158 for people with mild to moderate plaque psoriasis. For 28 days, 31 participants took either the drug or a placebo pill, followed by a safety check for another month. The main goal was to see if the drug was safe and well-tolerated, while also looking for early signs that it could reduce the severity of psoriasis patches.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accellacare North London
Northwood, United Kingdom
-
Accellacare Northamptonshire
Corby, United Kingdom
-
Accellacare South London
Orpington, United Kingdom
-
Accellacare Warwickshire
Coventry, United Kingdom
-
Accellacare Yorkshire
Shipley, United Kingdom
-
MEU
Manchester, United Kingdom
Conditions
Explore the condition pages connected to this study.